New HIV/AIDS Research Center in Cameroon to Help Develop Vaccine Against Vertical HIV Transmission
March 6, 2006
An HIV/AIDS research center in Yaounde, Cameroon, that opened last month plans to help develop a vaccine to prevent infants from contracting HIV through breast-feeding, SciDev.net reports. Breast-feeding might account for nearly half of all HIV infections in infants and children in areas where its use is widespread and prolonged, according to the World Health Organization. The Yaounde Center will conduct clinical trials of a vaccine being developed by Families First Africa, an international alliance led by UNESCO. The vaccine soon will be ready for safety tests, Vittorio Colizzi of the Tor Vergata University in Rome -- one of the center's partners -- said. The center also will train researchers from the region, seek to improve the capacity to diagnose HIV/AIDS in children and research HIV resistance to antiretroviral drugs used in Cameroon, Colizzi said. The Institute of Human Virology at the University of Maryland, the World Foundation for AIDS Research and Prevention and Italy's Higher Health Institute also are partnering with the center, which is funded by UNESCO, the Italian Health Ministry, the European Union and the Cameroonian government (Buma Gana, SciDev.net, 3/1).
National HIV/AIDS Strategic Plan
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2006 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.